Markets
Alerts
F&O
MF
Reports
Screeners
Subscribe
Superstars
Portfolio
Watchlist
Insider Trades
Results
Data Downloader
Events Calendar
What's New
Explore
FAQs
Widgets
More
Search stocks
IND
USA
IND
IND
×
Close
IND
USA
Stocks
Futures & Options
Mutual Funds
News
Fundamentals
Reports
Corporate Actions
Alerts
Shareholding
Stocks
Aurobindo Pharma Ltd.
Swot
Aurobindo Pharma Ltd. SWOT Analysis: Strengths, Weakness, Opportunity, and Threats
Aurobindo Pharma Ltd. has 10 Strengths, 10 Weaknesses, 10 Opportunities and 3 Threats. The SWOT product gives you a quick x-ray of a stock's outlook and potential
Add SWOT widget to your site/app
Strengths
(10)
Weakness
(10)
Opportunity
(10)
Threats
(3)
Others
(6)
Benjamin Graham Value Screen
Rising Net Cash Flow and Cash from Operating activity
PEG lower than Industry PEG
Effectively using its capital to generate profit - RoCE improving in last 2 years
Effectively using Shareholders fund - Return on equity (ROE) improving since last 2 year
Companies with Low Debt
Strong cash generating ability from core business - Improving Cash Flow from operation for last 2 years
Annual Net Profits improving for last 2 years
Book Value per share Improving for last 2 years
Top Gainers
Promoters increased pledged shares QoQ
Bearish Stocks - Stocks with Medium to Low Trendlyne Momentum Score
Near 52 Week Low
Weak Momentum: Price below Short, Medium and Long Term Averages
Degrowth in Revenue, Profits and Operating Profit Margin in recent results (QoQ)
RSI indicating price weakness
High promoter stock pledges
Highest increase in pledges by promoters
Near 52 Week Low
Stocks Underperforming their Industry Price Change in the Quarter
Broker price or reco upgrades in last month
Brokers upgraded recommendation or target price in the past three months
Mutual Funds Increased Shareholding in Past Month
Big Deal (Insider and SAST) buys last month greater than 1% of total shares
Street Favorite: High Analyst Rating with at least 20% upside
Broker Upgrades: Stocks where brokers upgraded recommendation or price target in the past one month
MFs increased their shareholding last quarter
Broker price or reco upgrades in last month
Mutual Funds Increased Shareholding over the Past Two Months
Mf buying for 2 months
Recent Broker Downgrades in Reco or Target Price
Broker downgrades in price or recommendation in the past one month
Red Flag: Companies seeing significant coronavirus impact
Indian stocks that could be impacted by Brexit (Britain leaving the EU)
Bullish or Bearish Candlestick Strength - Indices
Bullish Harami (Bullish Reversal)
Average Affordability - Stocks with Medium Trendlyne Valuation Score versus Benchmarks
Average Financial Performers - Stocks with Medium Trendlyne Durability Score versus Benchmarks
Decline in Net Profit with falling Profit Margin (QoQ)
